Economy News - Follow-up On Monday, shares of Novo Nordisk experienced a decline following the announcement of clinical results for CAGRISEMA, a new weight loss medication. This innovative drug demonstrated
Economic Insights - Company Performance Update Eli Lilly announced its financial results for the fourth quarter of 2024 on Thursday, revealing revenues that fell short of expectations, despite surpassing profit